On the Role of Paraoxonase-1 and Chemokine Ligand 2 (C-C motif) in Metabolic Alterations Linked to Inflammation and Disease. A 2021 Update

被引:23
作者
Camps, Jordi [1 ]
Castane, Helena [1 ]
Rodriguez-Tomas, Elisabet [1 ,2 ]
Baiges-Gaya, Gerard [1 ]
Hernandez-Aguilera, Anna [1 ]
Arenas, Meritxell [1 ,2 ]
Iftimie, Simona [3 ]
Joven, Jorge [1 ]
机构
[1] Univ Rovira & Virgili, Inst Invest Sanitaria Pere Virgili, Unitat Recerca Biomed, Hosp Univ St Joan, Reus 43201, Spain
[2] Univ Rovira & Virgili, Inst Invest Sanitaria Pere Virgili, Dept Radiat Oncol, Hosp Univ St Joan, Reus 43201, Spain
[3] Univ Rovira & Virgili, Inst Invest Sanitaria Pere Virgili, Dept Internal Med, Hosp Univ St Joan, Reus 43201, Spain
关键词
cancer; cardiovascular disease; chemokine (C-C motif) ligand 2; fatty liver; infection; inflammation; metabolism; obesity; paraoxonase-1; MONOCYTE CHEMOATTRACTANT PROTEIN-1; ENDOPLASMIC-RETICULUM STRESS; HIGH-DENSITY-LIPOPROTEINS; HEPATITIS-B-VIRUS; SERUM PARAOXONASE; OXIDATIVE STRESS; HELICOBACTER-PYLORI; ARYLESTERASE ACTIVITIES; PON1; STATUS; IMMUNOHISTOCHEMICAL ANALYSIS;
D O I
10.3390/biom11070971
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Infectious and many non-infectious diseases share common molecular mechanisms. Among them, oxidative stress and the subsequent inflammatory reaction are of particular note. Metabolic disorders induced by external agents, be they bacterial or viral pathogens, excessive calorie intake, poor-quality nutrients, or environmental factors produce an imbalance between the production of free radicals and endogenous antioxidant systems; the consequence being the oxidation of lipids, proteins, and nucleic acids. Oxidation and inflammation are closely related, and whether oxidative stress and inflammation represent the causes or consequences of cellular pathology, both produce metabolic alterations that influence the pathogenesis of the disease. In this review, we highlight two key molecules in the regulation of these processes: Paraoxonase-1 (PON1) and chemokine (C-C motif) ligand 2 (CCL2). PON1 is an enzyme bound to high-density lipoproteins. It breaks down lipid peroxides in lipoproteins and cells, participates in the protection conferred by HDL against different infectious agents, and is considered part of the innate immune system. With PON1 deficiency, CCL2 production increases, inducing migration and infiltration of immune cells in target tissues and disturbing normal metabolic function. This disruption involves pathways controlling cellular homeostasis as well as metabolically-driven chronic inflammatory states. Hence, an understanding of these relationships would help improve treatments and, as well, identify new therapeutic targets.
引用
收藏
页数:26
相关论文
共 267 条
  • [1] A complex secretory program orchestrated by the inflammasome controls paracrine senescence
    Acosta, Juan Carlos
    Banito, Ana
    Wuestefeld, Torsten
    Georgilis, Athena
    Janich, Peggy
    Morton, Jennifer P.
    Athineos, Dimitris
    Kang, Tae-Won
    Lasitschka, Felix
    Andrulis, Mindaugas
    Pascual, Gloria
    Morris, Kelly J.
    Khan, Sadaf
    Jin, Hong
    Dharmalingam, Gopuraja
    Snijders, Ambrosius P.
    Carroll, Thomas
    Capper, David
    Pritchard, Catrin
    Inman, Gareth J.
    Longerich, Thomas
    Sansom, Owen J.
    Aznar Benitah, Salvador
    Zender, Lars
    Gil, Jesus
    [J]. NATURE CELL BIOLOGY, 2013, 15 (08) : 978 - U221
  • [2] Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis
    Adekoya, Timothy O.
    Richardson, Ricardo M.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (12) : 1 - 29
  • [3] Targeting kinases with thymoquinone: a molecular approach to cancer therapeutics
    Afrose, Syeda Samira
    Junaid, Md.
    Akter, Yeasmin
    Tania, Mousumi
    Zheng, Meiling
    Khan, Md. Asaduzzaman
    [J]. DRUG DISCOVERY TODAY, 2020, 25 (12) : 2294 - 2306
  • [4] Afsar CU, 2015, INT J CLIN EXP MED, V8, P21599
  • [5] Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab
    Agresti, Nicholas
    Lalezari, Jacob P.
    Amodeo, Phillip P.
    Mody, Kabir
    Mosher, Steven F.
    Seethamraju, Harish
    Kelly, Scott A.
    Pourhassan, Nader Z.
    Sudduth, C. David
    Bovinet, Christopher
    ElSharkawi, Ahmed E.
    Patterson, Bruce K.
    Stephen, Reejis
    Sacha, Jonah B.
    Wu, Helen L.
    Gross, Seth A.
    Dhody, Kush
    [J]. JOURNAL OF TRANSLATIONAL AUTOIMMUNITY, 2021, 4
  • [6] The assessment of carotid intima media thickness and serum Paraoxonase-1 activity in Helicobacter pylori positive subjects
    Akbas, Halide S.
    Basyigit, Sebahat
    Suleymanlar, Inci
    Kemaloglu, Didem
    Koc, Serkan
    Davran, Fatih
    Demir, Ibrahim
    Suleymanlar, Gultekin
    [J]. LIPIDS IN HEALTH AND DISEASE, 2010, 9
  • [7] Oxidant and antioxidant of arylesterase and paraoxonase as biomarkers in patients with hepatitis C virus
    Ali, Ehab M. M.
    Shehata, Hanan Hussien
    Ali-Labib, Randa
    Zahra, Lamia M. Esmail
    [J]. CLINICAL BIOCHEMISTRY, 2009, 42 (13-14) : 1394 - 1400
  • [8] Host-pathogen interactions in the development of metabolic disturbances and atherosclerosis in HIV infection: The role of CCL2 genetic variants
    Alonso-Villaverde, Carlos
    Aragones, Gerard
    Beltran-Debon, Raul
    Fernandez-Sender, Laura
    Rull, Anna
    Rodriguez-Sanabria, Fernando
    Marsillach, Judit
    Pardo-Reche, Pedro
    Camps, Jordi
    Joven, Jorge
    [J]. CYTOKINE, 2010, 51 (03) : 251 - 258
  • [9] Metabolomics in early detection and prognosis of acute coronary syndrome
    Amiri, Mohammad Pouralijan
    Khoshkam, Maryam
    Salek, Reza M.
    Madadi, Reza
    Ganji, Ghassem Faghanzadeh
    Ramazani, Ali
    [J]. CLINICA CHIMICA ACTA, 2019, 495 : 43 - 53
  • [10] Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?
    Andersson, Ulf
    Ottestad, William
    Tracey, Kevin J.
    [J]. MOLECULAR MEDICINE, 2020, 26 (01)